Dean's Innovation Fund

Lab of Microbiology & Immunology Professor Terry Connell.

This fund provides critical financial support for new and emerging initiatives throughout the school.

The Dean’s Innovation Fund provides the Dean of the Jacobs School of Medicine and Biomedical Sciences unrestricted funds to respond rapidly and flexibly to ideas as they arise.

From our founding as a medical school in 1846, to paving the way for future physicians, the Jacobs School of Medicine and Biomedical Sciences builds upon its proud legacy of teaching, patient care and scientific discovery.

The fund was established in 2000 by Ronald Garvey, M.D. '53, in support of the school—one of the oldest medical schools in the United States.

At the Jacobs School of Medicine and Biomedical Sciences, we strive to attract the most promising individuals and support their development; enhance our intellectual and technological environment to foster exceptionally creative science and education; develop and maintain excellent clinical programs to provide outstanding care; cultivate excellence, collegiality, and diversity; observe the highest standards of ethics, integrity, professionalism, and humanism; and apply advances in science, medicine, and education to the betterment of humanity.

Make a Difference Now

Other Jacobs School of Medicine and Biomedical Sciences Funds

News from the Jacobs School of Medicine and Biomedical Sciences

  • Popescu Recipient of NINDS Research Program Award
    5/3/23

    Gabriela K. Popescu, PhD, professor of biochemistry in the Jacobs School of Medicine and Biomedical Sciences, is the first SUNY-affiliated recipient of the National Institute of Neurological Disorders and Stroke (NINDS) Research Program Award (R35).

  • Ending Race-Based Health Disparities
    10/27/23

    The Igniting Hope conference has matured into a movement aimed at bringing lasting change to the region by ending race-based disparities and their devastating impacts.

  • New Therapeutic Targets for Endometriosis Goal of Study
    8/9/23

    New research on the connection between endometrial lesions and pain in endometriosis could lead to new therapies for this chronic, painful and poorly understood condition.

  • Study Focuses on Brain Lesions, MS Progression
    2/24/23

    Brain lesions — areas of brain tissue that show damage from injury or disease — are the biomarker most widely used to determine multiple sclerosis disease progression. But an innovative new study led by the University at Buffalo strongly suggests that the volume of white matter lesions is neither proportional to, nor indicative of, the degree of severe disability in patients. 

  • A Team Approach to Mental Health
    5/31/22

    Because of the work of the Patrick P. Lee Foundation, training programs have been a success at UB that increase the number of highly skilled mental health workers in Western New York.

  • Dubocovich Delivers Axelrod Lecture, Arranges Symposium
    8/21/23

    Margarita L. Dubocovich, PhD, SUNY Distinguished Professor of pharmacology and toxicology, delivered the Julius Axelrod Lecture and organized the Axelrod Symposium at the 2023 annual meeting of The American Society for Pharmacology and Experimental Therapeutics (ASPET).

  • Family-Focused Child Weight-Loss Treatment Works Best
    6/13/23

    Family-based treatment for obesity conducted in the pediatrician’s office leads to improved weight-loss outcomes for the treated child and parent, and even extends to untreated siblings.